Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00362115 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

A Phase 2 study of Hypertension, sponsored by Takeda.

Completed
Registry status
Phase 2
Development phase
449
Enrollment target
20
Study locations

NCT00362115 is a Phase 2 study of Hypertension that has completed, run by Takeda. The registered enrollment target is 449 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00362115, a Phase 2 study of Hypertension, has completed, sponsored by Takeda.

COMPLETED
Registry status
Phase 2
Development phase
449 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan medoxomil, once daily (QD), in individuals with hypertension.

Conditions Studied

Hypertension

Interventions

  • DRUG Azilsartan Medoxomil

Study Locations (20)

Florida

  • - Hollywood
  • - Jacksonville
  • - Melbourne
  • - Miami
  • - Pembroke Pines
  • - Pinellas Park

California

  • - Carmichael
  • - Long Beach
  • - San Diego
  • - Tustin

Connecticut

  • - Stamford
  • - Trumbull
  • - Waterbury

Alabama

  • - Huntsville
  • - Ozark

Arizona

  • - Mesa

Arkansas

  • - Little Rock

Colorado

  • - Denver

Georgia

  • - Atlanta

Trial Details

FieldValue
Enrollment Target 449 participants
Start Date 2006-05
Est. Completion 2006-12
Phase Phase 2

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00362115

The ClinicalTrials.gov registry entry for NCT00362115 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 449 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (87% lower). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Azilsartan Medoxomil is the first listed.

NCT00362115 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT00362115 about?

NCT00362115 is a clinical study titled "Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension". The purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan medoxomil, once daily (QD), in individuals with hypertension.

What is the current status of trial NCT00362115?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 449 participants. The study started on 2006-05. Estimated completion is 2006-12.

What conditions does trial NCT00362115 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00362115?

The interventions under investigation include: Azilsartan Medoxomil (DRUG).

Who is sponsoring clinical trial NCT00362115?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00362115 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.